海角社区

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

ADMET

29 - 30 June 2015, London, United Kingdom


Introduction
SMi鈥檚 10th Annual ADMET conference will provide essential insight into the latest novel technologies being used in the field of Predictive Toxicology and ADME/Tox. With drug induced liver and Cardiotoxicity still being major causes of drug attrition rates, the programme will feature case studies on development of human cellular models and state-of-the-art in vitro used to assess toxicity. This is a must attend event if you want to be at the forefront of pharmacokinetic/pharmacodynamic models; drug transporter assays in drug discovery; time-dependent inhibition screens in early drug discovery; the system-dependent inhibition of CYP enzymes and the integrating predictive toxicology framework.

Reasons why you should attend:

鈥n vitro models and technologies for detecting Cardiotoxicity
鈥nalyse performance of different in vitro models to detect human hepatotoxic drugs
鈥uman stem cell derived cardiomyocytes
鈥egulatory DDI Guidance(s) for drug transporters - an overview review of current FDA, EMA and JMHLW (Japan) guidance for industry
鈥itigating errors in early human dose predictions and setting the criteria for ADME end points

Keynote speakers include:

鈥raz Raoof, Head Scientific Affairs & Analysis, Janssen Pharmaceutical
鈥rofessor Ian D. Wilson, Professor of Drug Metabolism, Imperial College London
鈥aurent Salphati, Senior Scientist, Genentech
鈥hierry Lave, Global Head DMPK & Tox Project Leaders and Modelling & Simulation, F. Hoffmann-La Roche
鈥eter Clements, Director of Pathology, GSK
鈥tephen Fowler, Group Leader, In Vitro ADME, F. Hoffmann-La Roche
鈥ranck Atienzar, Associate Director In Silico In Vitro Toxicology, UCB BioPharma SPRL
鈥eter Hoffmann, Executive Director, Pre-Clinical Safety, Novartis Institutes for BioMedical Research
鈥ario Monshouwer, Senior Director Drug Metabolism Pharmacokinetics & Bioanalysis, Johnson & Johnson

In addition, don鈥檛 miss the post-conference workshop taking place on the 1st July:
鈥 ADME(T) Strategies for Pharmacological Space Beyond Ro5 and Eukaryotic Enzyme Inhibitors
Workshop Leader: Constance H枚fer, Chief Development Officer, Priaxon AG

HOW TO REGISTER
Register online using the book now button
Contact Magdalena Georgieva on +44 (0)20 7827 6148 or email mgeorgieva@smi-online.co.uk

Useful links

Venue
London Marriott Hotel Regents Park

London Marriott Hotel Regents Park, 128 King Henry's Road, London, NW3 3ST, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*